Testing effectiveness (Phase 2)Looking for participantsNCT06941766
What this trial is testing
Iparomlimab and Tuvonralimab (QL1706) for Intermediate Trophoblastic Tumors
Who this might be right for
Intermediate Trophoblastic Tumor
Peking Union Medical College Hospital 20